Vor Biopharma Inc (NASDAQ:VOR) has a beta value of -0.52 and has seen 36.69 million shares traded in the last trading session. The company, currently valued at $36.24M, closed the last trade at $0.29 per share which meant it gained $0.05 on the day or 20.68%% during that session. The VOR stock price is -520.69% off its 52-week high price of $1.80 and 55.17% above the 52-week low of $0.13. If we look at the company’s 10-day average daily trading volume, we find that it stood at 5.38 million shares traded. The 3-month trading volume is 2.23 million shares.
The consensus among analysts is that Vor Biopharma Inc (VOR) is Buy stock at the moment, with a recommendation rating of 3.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight.
Vor Biopharma Inc (NASDAQ:VOR) trade information
Sporting 20.68%% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the VOR stock price touched $0.29 or saw a rise of 23.68%. Year-to-date, Vor Biopharma Inc shares have moved -75.83%, while the 5-day performance has seen it change 59.25%. Over the past 30 days, the shares of Vor Biopharma Inc (NASDAQ:VOR) have changed 58.73%. Short interest in the company has seen 4.19 million shares shorted with days to cover at 0.85.
Wall Street analysts have a consensus price target for the stock at $6, which means that the shares’ value could jump 95.17% from current levels. The projected low price target is $6.0 while the price target rests at a high of $6.0. In that case, then, we find that the current price level is -1968.97% off the targeted high while a plunge would see the stock gain -1968.97% from current levels.
Vor Biopharma Inc (VOR) estimates and forecasts
The company’s shares have lost -70.30% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -38.02% over the past 5 years. Earnings growth for 2025 is a modest 58.59% while over the next 5 years, the company’s earnings are expected to increase by 33.72%.
VOR Dividends
Vor Biopharma Inc is expected to release its next earnings report on 2025-May-14 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Vor Biopharma Inc (NASDAQ:VOR)’s Major holders
Insiders own 31.89% of the company shares, while shares held by institutions stand at 48.76% with a share float percentage of 71.59%. Investors are also buoyed by the number of investors in a company, with Vor Biopharma Inc having a total of 60.0 institutions that hold shares in the company. The top two institutional holders are RA CAPITAL MANAGEMENT, L.P. with over 22.75 million shares worth more than $22.75 million. As of 2024-06-30, RA CAPITAL MANAGEMENT, L.P. held 33.439% of shares outstanding.
The other major institutional holder is FMR LLC, with the holding of over 7.08 million shares as of 2024-06-30. The firm’s total holdings are worth over $7.08 million and represent 10.4009% of shares outstanding.
